To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Waud commits $100m-plus to medication-based services initiative
The Chicago PE firm has teamed up with Paul Jardina, who most recently served as the CEO of Onco360, an oncology-focused specialty pharmacy.
